J1212 HCPCS code: Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
J1212 is the HCPCS Level II code for injection, dmso, dimethyl sulfoxide, 50%, 50 ml. In 2024 Medicare paid an average of $513.89 per service for J1212 across 4,927 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 1 per day on outpatient hospital claims. Medicare volume fell 8% from 2022 to 2024 (5,369 to 4,927 services). In 2024, about 300 clinicians billed Medicare for J1212 for 566 beneficiaries; California, Pennsylvania, Virginia accounted for 76% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 2017-01-01 |
Who bills J1212 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 300 |
| Medicare beneficiaries | 566 |
| States with claims | 16 |
| Share of services in top 3 states (California, Pennsylvania, Virginia) | 76% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1212, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 5,369 | 714 | $575.23 | $455.73 |
| 2023 | 4,703 | 601 | $611.37 | $484.53 |
| 2024 | 4,927 | 566 | $648.49 | $513.89 |
States with the most J1212 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 2,632 | $528.56 |
| Pennsylvania | 571 | $524.43 |
| Virginia | 231 | $537.58 |
| Florida | 175 | $532.38 |
| Massachusetts | 158 | $543.29 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1 | Prescribing Information |
| practitioner claims | 1 | Prescribing Information |
What changed for J1212
- 1986-01-01: J1212 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1212?
J1212 is the HCPCS Level II code for injection, dmso, dimethyl sulfoxide, 50%, 50 ml. Short descriptor: "Dimethyl sulfoxide 50% 50 ml".
How much does Medicare pay for J1212?
In 2024, the average Medicare payment was $513.89 per service (average allowed $648.49).
Does Medicare cover J1212?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J1212 can be billed per day?
1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related J12 codes
- J1200 — Injection, diphenhydramine hcl, up to 50 mg
- J1201 — Injection, cetirizine hydrochloride, 0.5 mg
- J1202 — Miglustat, oral, 65 mg
- J1203 — Injection, cipaglucosidase alfa-atga, 5 mg
- J1205 — Injection, chlorothiazide sodium, per 500 mg
- J1230 — Injection, methadone hcl, up to 10 mg
- J1240 — Injection, dimenhydrinate, up to 50 mg
- J1245 — Injection, dipyridamole, per 10 mg
- J1250 — Injection, dobutamine hydrochloride, per 250 mg
- J1260 — Injection, dolasetron mesylate, 10 mg
- J1265 — Injection, dopamine hcl, 40 mg
- J1267 — Injection, doripenem, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1212
- Watch J1212 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1212
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.